肝水解肽注射液致过敏性休克1例分析  

Case Analysis of Anaphylactic Shock Induced by Heparolysate Injection

作　　者：刘艳秋[1] 唐立民[1] 

机构地区：[1]吉林省肿瘤医院药剂科,吉林长春130012

出　　处：《中国执业药师》2014年第1期44-46,共3页China Licensed Pharmacist

摘　　要：报道分析1例女性乳腺癌患者静脉滴注肝水解肽注射液后突然出现过敏性休克的病例,检索国内文献曾发生过类似的报道。提示肝水解肽注射液可致严重的过敏反应,临床应加以监测。It was reported that a case of female patient with breast cancer got anaphylactic shock after receiving intravenous drip of heparolysate injection. The information retrieving showed that there were similar reports in domestic literatures. It was reminded that heparolysate injection can cause serious allergic reactions and attention should be paid to monitoring in clinical practice.

关 键 词：水解肽注射液 过敏性休克 严重不良反应 

分 类 号：R593.1[医药卫生—内科学]